7Baggers
 Arcutis Biotherapeutics Hits New 52-Week High of $20.10, Up 162%  Markets Mojo Thu, 02 Oct 2025 19:53:14 GMT
 Arcutis Biotherapeutics Hits New 52-Week High of $19.36  Markets Mojo Wed, 01 Oct 2025 18:50:20 GMT
 Arcutis Biotherapeutics stock hits 52-week high at 18.17 USD By Investing.com  Investing.com Nigeria Mon, 29 Sep 2025 16:21:00 GMT
 Biotech Leader Arcutis Is Breaking Out, Up Nearly 36% In 2025  Investor's Business Daily Mon, 29 Sep 2025 15:33:00 GMT
 published on: 2025-09-20 11:38:58  خودرو بانک Sat, 20 Sep 2025 08:09:53 GMT
 invst llc invests $323,000 in arcutis biotherapeutics, inc. $arqt  MarketBeat Thu, 18 Sep 2025 02:54:24 GMT
 arcutis biotherapeutics (arqt) unveils positive data on zoryve f  GuruFocus Wed, 17 Sep 2025 09:50:16 GMT
 published on: 2025-09-15 14:30:32  خودرو بانک Mon, 15 Sep 2025 11:00:46 GMT
 9 of the Fastest-Growing Biotech Stocks Under $10 Billion  TIKR.com Sat, 13 Sep 2025 07:00:00 GMT
 arcutis biotherapeutics ceo watanabe sells $177k in shares by investing.com  Investing.com South Africa Thu, 11 Sep 2025 04:54:24 GMT
 arcutis biotherapeutics stock hits 52-week high at 17.76 usd by investing.com  Investing.com Australia Wed, 10 Sep 2025 08:28:29 GMT
 Arcutis Biotherapeutics CEO Watanabe sells $177k in shares  Investing.com Wed, 10 Sep 2025 07:00:00 GMT
 Arcutis Biotherapeutics (ARQT) Surges 31% In Last Quarter  simplywall.st Wed, 10 Sep 2025 07:00:00 GMT
 Arcutis at H.C. Wainwright: Strategic Growth and Pipeline Development  Investing.com Wed, 10 Sep 2025 07:00:00 GMT
 arcutis at morgan stanley conference: zoryve’s strategic growth by investing.com  Investing.com South Africa Wed, 10 Sep 2025 00:28:35 GMT
 Arcutis Biotherapeutics stock hits 52-week high at 17.76 USD  Investing.com Tue, 09 Sep 2025 07:00:00 GMT
 arcutis at morgan stanley conference: zoryve’s strategic growth  Investing.com Tue, 09 Sep 2025 07:00:00 GMT
 matsuda masaru sells arcutis biotherapeutics (arqt) shares for $583k by investing.com  Investing.com South Africa Tue, 09 Sep 2025 06:30:19 GMT
 Matsuda Masaru sells Arcutis Biotherapeutics (ARQT) shares for $583k  Investing.com Mon, 08 Sep 2025 07:00:00 GMT
 Arcutis Biotherapeutics jumps amid takeover speculation  MSN Fri, 05 Sep 2025 11:37:43 GMT
 welgus, arcutis director, sells $156k in shares  Investing.com Fri, 05 Sep 2025 00:30:17 GMT
 welgus, arcutis director, sells $156k in shares by investing.com  Investing.com Australia Thu, 04 Sep 2025 23:56:54 GMT
 august's fda focus: approvals and pipeline updates in pediatrics  Contemporary Pediatrics Thu, 04 Sep 2025 18:45:00 GMT
 arcutis seeks fda approval for psoriasis cream for young children by investing.com  Investing.com Australia Thu, 04 Sep 2025 13:11:42 GMT
 welgus, arcutis director, sells $156k in shares  Investing.com Thu, 04 Sep 2025 07:00:00 GMT
 arcutis seeks expanded indication for zoryve  MarketScreener Wed, 03 Sep 2025 16:54:07 GMT
 arcutis at citi’s biopharma conference: strategic growth insights  Investing.com Wed, 03 Sep 2025 15:47:44 GMT
 arcutis seeks fda approval for psoriasis cream for young children  Investing.com Wed, 03 Sep 2025 07:00:00 GMT
 arcutis biotherapeutics sybmits snda for zoryve cream 0.3%  TipRanks Wed, 03 Sep 2025 07:00:00 GMT
 hcplive 5 stories in under 5: week of 08/24  HCPLive Tue, 02 Sep 2025 23:38:39 GMT
 adherence challenges take center stage in psoriasis management  Dermatology Times Tue, 02 Sep 2025 13:08:42 GMT
 published on: 2025-08-31 13:24:11  Newser Sun, 31 Aug 2025 18:24:11 GMT
 published on: 2025-08-29 13:09:20  Newser Fri, 29 Aug 2025 18:09:20 GMT

Arcutis Biotherapeutics, Inc
(NASDAQ:ARQT) 

ARQT stock logo

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atop...

Founded: 2016
Full Time Employees: 53
CEO: Todd Franklin Watanabe  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends